Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China · Delayed Price · Currency is CNY 319.07
+12.00 (3.91%)
Aug 10, 2026, 4:00 PM EDT
SHA:688506 Market Cap
SHA:688506 has a market cap or net worth of 131.74 billion as of August 10, 2026. Its market cap has increased by 11.19% in one year.
Market Cap
131.74B
Enterprise Value
131.03B
Revenue
2.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
319.07
ChartMarket Cap Chart
Since January 6, 2023, SHA:688506's market cap has increased from 12.85B to 131.74B, an increase of 925.02%. That is a compound annual growth rate of 91.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 131.74B | -1.25% |
| Dec 31, 2025 | 133.40B | 73.51% |
| Dec 31, 2024 | 76.88B | 37.05% |
| Dec 29, 2023 | 56.10B | 336.51% |
| Jan 6, 2023 | 12.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 360.45B |
| Zhejiang NHU Company | 93.92B |
| Yunnan Baiyao Group Co.,Ltd | 90.57B |
| Shanghai Fosun Pharmaceutical (Group) | 57.77B |
| Huadong Medicine | 50.84B |
| China Resources Sanjiu Medical & Pharmaceutical | 41.82B |
| Shenzhen Salubris Pharmaceuticals | 40.17B |
| Beijing Tongrentang | 34.34B |